{"database": "lobbying", "table": "lobbying_activities", "rows": [[3006801, "0de0ec95-27b3-407e-a4d3-551d9ef2021d", "Q2", "RICCHETTI INCORPORATED", 62778, "IPSEN BIOPHARMACEUTICALS, INC.", 2023, "second_quarter", "PHA", "Issues related to pharmaceutical industry, generally Issues related to development of products to treat limb spasticity and fibrodysplasia ossificans progressiva (FOP)", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2023-07-17T11:50:01-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3006801"], "units": {}, "query_ms": 149.66854196973145, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}